
Quotient Limited QTNT
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Quotient Limited Kurzfristige Verbindlichkeiten 2011-2026 | QTNT
Kurzfristige Verbindlichkeiten Jährlich Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 59.5 M | 31.2 M | 25.4 M | 27.1 M | 29.7 M | 21.4 M | 54.8 M | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 59.5 M | 21.4 M | 35.6 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.71 B | $ 110.24 | -2.87 % | $ 33.5 B | ||
|
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M | ||
|
Biodesix
BDSX
|
14.3 M | $ 14.21 | -2.67 % | $ 1.84 B | ||
|
Biomerica
BMRA
|
1.74 M | $ 2.01 | -4.74 % | $ 4.62 M | ||
|
Burning Rock Biotech Limited
BNR
|
372 M | $ 16.36 | -11.57 % | $ 176 M | ||
|
Sotera Health Company
SHC
|
250 M | $ 13.13 | -3.03 % | $ 3.73 B | ||
|
Celcuity
CELC
|
44.2 M | $ 106.02 | -7.66 % | $ 4.96 B | ||
|
Check-Cap Ltd.
CHEK
|
1.81 M | - | - | $ 9.42 M | ||
|
DarioHealth Corp.
DRIO
|
9.32 M | $ 8.11 | -4.02 % | $ 32.3 M | ||
|
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M | ||
|
BioNano Genomics
BNGO
|
22.9 M | $ 1.16 | 0.87 % | $ 6.32 M | ||
|
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
2.14 B | $ 62.25 | -5.81 % | $ 24.3 B | ||
|
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | ||
|
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
49.4 M | $ 23.53 | -4.74 % | $ 654 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
1.12 B | $ 159.16 | -3.62 % | $ 7.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 195.51 | -1.22 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
3.74 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
634 K | - | -16.95 % | $ 1.54 M | ||
|
Guardant Health
GH
|
303 M | $ 84.61 | -3.96 % | $ 10.6 B | ||
|
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
2.8 B | $ 102.08 | -0.97 % | $ 8.42 B | ||
|
IDEXX Laboratories
IDXX
|
1.15 B | $ 558.32 | -2.61 % | $ 44.9 B | ||
|
Illumina
ILMN
|
1.55 B | $ 117.67 | -5.41 % | $ 18.7 B | ||
|
PerkinElmer
PKI
|
1.33 B | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | ||
|
IQVIA Holdings
IQV
|
8.34 B | $ 163.85 | -3.28 % | $ 28.2 B | ||
|
Interpace Biosciences
IDXG
|
10.6 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
544 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
174 M | $ 8.7 | -4.92 % | $ 1.89 B | ||
|
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 264.2 | -1.56 % | $ 22 B | ||
|
Psychemedics Corporation
PMD
|
4.71 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
3.14 M | $ 25.97 | -4.52 % | $ 33.7 M | ||
|
CareDx, Inc
CDNA
|
89.8 M | $ 16.78 | -3.95 % | $ 894 M | ||
|
Syneos Health
SYNH
|
1.65 B | - | - | $ 4.46 B |